FDA Accepts Ultragenyx (RARE) BLA for Sanfilippo Syndrome Gene Therapy UX111

Ultragenyx (NASDAQ:RARE) is 1 of the overlooked maturation stocks to bargain now. On April 2, Ultragenyx announced that the US FDA accepted the resubmitted BLA for UX111, an investigational AAV9 cistron therapy for Sanfilippo syndrome Type A (MPS IIIA). The FDA acceptable a PDUFA enactment day of September 19 for its decision. If approved, UX111 would go the archetypal disposable attraction for this rare, fatal familial disorder, which causes progressive and irreversible neurodegeneration successful young children.

The therapy, besides known arsenic rebisufligene etisparvovec, is simply a one-time intravenous infusion designed to present a functional transcript of the SGSH gene. This addresses the underlying enzyme deficiency liable for the toxic accumulation of heparan sulfate successful the brain. Clinical information included successful the BLA, spanning up to 8 years of follow-up, show a durable attraction effect and objective betterment compared to the earthy progression of the disease. The FDA antecedently acknowledged the robustness of the neurodevelopmental and biomarker information during the anterior reappraisal cycle.

Pixabay/Public domain

Sanfilippo syndrome Type A is caused by a deficiency of the sulfamidase enzyme, starring to a median beingness expectancy of lone 15 years. Ultragenyx’s UX111 received aggregate high-level regulatory designations, including Fast Track and Rare Pediatric Disease status. If granted accelerated approval, the therapy volition beryllium manufactured astatine specialized facilities successful Ohio and Massachusetts, providing a captious caller enactment for a assemblage presently without immoderate approved disease-modifying treatments.

Ultragenyx (NASDAQ:RARE) is simply a biotech institution that is focused connected bringing caller products to patients for the attraction of superior uncommon and ultra-rare familial diseases.

While we admit the imaginable of RARE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.